Not Signed In - |
|
|
|
Clinical Trials
- V260 Registration Study
ClinicalTrials.gov Identifier: NCT00166517 - Active, not recruiting
Gastrointestinal Rotavirus
- V260, Concomitant Use of V260 and DTacP in Healthy Infants
ClinicalTrials.gov Identifier: NCT00258154 - Active, not recruiting
Rotavirus Disease
- V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
ClinicalTrials.gov Identifier: NCT00175513 - Recruiting
Psychosis
- V501 (Gardasil) Study in Preadolescent Females
ClinicalTrials.gov Identifier: NCT00411749 - Active, not recruiting
Papillomavirus Infections
- V930 First in Man (FIM) Study
ClinicalTrials.gov Identifier: NCT00250419 - Active, not recruiting
Cancers Expressing HER-2 and/or CEA
- VA Genetic Tissue Banking
ClinicalTrials.gov Identifier: NCT00032578 - Completed
Tissue Banking
- VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis
ClinicalTrials.gov Identifier: NCT00035711 - Completed
Coronary Disease; Heart Diseases; Cardiovascular Diseases; Carotid Artery Diseases; Diabetes Mellitus, non-insulin dependent; Hypertension; ...
- VA Low Vision Intervention Trial
ClinicalTrials.gov Identifier: NCT00223756 - Recruiting
Vision, Low
- VA MI Plus
ClinicalTrials.gov Identifier: NCT00126750 - Recruiting
Myocardial Infarction; Comorbidities
- VA NEPHRON-D Study
ClinicalTrials.gov Identifier: NCT00555217 - Not yet recruiting
Type 2 Diabetes; Renal Transplant; Kidney Disease; Nephropathy; Hyperkalemia
- Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
ClinicalTrials.gov Identifier: NCT00027131 - Terminated
Breast Neoplasms
- Vaccination Against Melanoma and Other Cancers
ClinicalTrials.gov Identifier: NCT00006074 - Completed
Breast Cancer; Colorectal Cancer; Melanoma; Non Small Cell Lung Carcinoma; Sarcoma
- Vaccination for Middle Ear Infection
ClinicalTrials.gov Identifier: NCT00001605 - Completed
- Vaccination for Patients With High Risk Cancers of the Blood
ClinicalTrials.gov Identifier: NCT00433745 - Recruiting
Myelodysplastic Syndrome; Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML)
- Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
ClinicalTrials.gov Identifier: NCT00487305 - Recruiting
Follicular Lymphoma
- Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00116467 - Completed
Acute Myelogenous Leukemia
- Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00116441 - Completed
Multiple Myeloma
- Vaccination of Children Following Allogeneic Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00169728 - Active, not recruiting
Allogeneic Haematopoietic Stem Cell Transplantation
- Vaccination of Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype
ClinicalTrials.gov Identifier: NCT00001572 - Active, not recruiting
B Cell Lymphoma; Follicular Lymphoma; Neoplasm
- Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells
ClinicalTrials.gov Identifier: NCT00515983 - Completed
Melanoma
- Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
ClinicalTrials.gov Identifier: NCT00458536 - Recruiting
Renal Cancer
- Vaccination of Patients with Stage IV Melanoma with Dendritic Cells
ClinicalTrials.gov Identifier: NCT00125749 - Recruiting
Stage IV metastatic melanoma
- Vaccination Plus Ontak in Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00515528 - Recruiting
Melanoma
- Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)
ClinicalTrials.gov Identifier: NCT00140374 - Completed
Prostate Cancer
- Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00279734 - Completed
Rheumatoid Arthritis
- Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003279 - Active, not recruiting
limited stage small cell lung cancer; Quality of Life
- Vaccination to Treat Melanoma in the Adjuvant Setting
ClinicalTrials.gov Identifier: NCT00006287 - Completed
Melanoma
- Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients
ClinicalTrials.gov Identifier: NCT00317603 - Recruiting
Breast Cancer
- Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00458653 - Recruiting
Multiple Myeloma
- Vaccination with tetanus and KLH to assess immune responses.
ClinicalTrials.gov Identifier: NCT00000105 - Recruiting
Cancer
- Vaccination with Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens
ClinicalTrials.gov Identifier: NCT00204516 - Not yet recruiting
Malignant Melanoma
- Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients with HIV
ClinicalTrials.gov Identifier: NCT00011011 - Completed
HIV Infections
- Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00048893 - Recruiting
Breast Neoplasms; Metastases, Neoplasm
- Vaccine and Combined Chemotherapy/Radiotherapy to Treat Inoperable Lung Cancer
ClinicalTrials.gov Identifier: NCT00088725 - Recruiting
Carcinoma; Non-Small Cell Lung
- Vaccine Efficacy ag Rotavirus Diarrhoea; Vaccine Given w Routine Childhood Vaccinations in Healthy African Infants
ClinicalTrials.gov Identifier: NCT00241644 - Recruiting
Prophylaxis Rotavirus
- Vaccine for Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00006491 - Completed
Cancer
- Vaccine for Recurrent Urinary Tract Infections in Women
ClinicalTrials.gov Identifier: NCT00261248 - Completed
Recurrent Urinary Tract Infections in Women
- Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00420732 - Recruiting
Carcinoma, Non-Small-Cell Lung
- Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00005949 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Plus Interleukin-2 Treatment of Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00051610 - Completed
Melanoma
- Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00079157 - Recruiting
recurrent breast cancer; stage IV breast cancer
- Vaccine Study for Surgically Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00569387 - Recruiting
Pancreatic Cancer
- Vaccine study of MVA-MUC1-IL2 in patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00040170 - Terminated
Prostatic Neoplasms
- Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00313508 - Recruiting
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00019084 - Completed
Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer
- Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00027833 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
- Vaccine Therapy and Detection of Immunologic Responses with Human Papillomavirus 16 E6 and E7 Peptides in Patients with Metastatic or Locally Advanced Cervical Cancer and Other Cancers Carrying the HPV
ClinicalTrials.gov Identifier: NCT00001441 - Completed
Anus Neoplasm; Cervix Neoplasm; Esophageal Neoplasm; Head and Neck Neoplasm; Papovaviridae Infection
- Vaccine Therapy and Detection of Immunologic Responses with Tumor Specific Mutated RAS Peptides in Adult Cancer Patients with Solid Tumors
ClinicalTrials.gov Identifier: NCT00001380 - Completed
Neoplasm
- Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
ClinicalTrials.gov Identifier: NCT00006216 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; childhood thorax/respiratory cancer
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
ClinicalTrials.gov Identifier: NCT00454168 - Recruiting
Leukemia
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
ClinicalTrials.gov Identifier: NCT00398138 - Recruiting
Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Peritoneal Cavity Cancer
- Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00513578 - Recruiting
Myelodysplastic Syndromes
- Vaccine Therapy and GM-CSF in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00313638 - Completed
Myelodysplastic Syndromes
- Vaccine Therapy and GM-CSF in Treating Patients With Myeloid Cancer
ClinicalTrials.gov Identifier: NCT00499772 - Recruiting
Leukemia; Myelodysplastic Syndromes
- Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00104819 - Recruiting
recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00436930 - Recruiting
Melanoma (Skin)
- Vaccine Therapy and GM-CSF in Treating Patients With Stage III or Stage IV Breast Cancer or Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00436254 - Recruiting
Breast Cancer; Ovarian Cancer
- Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00470015 - Suspended
Melanoma (Skin)
- Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00301093 - Active, not recruiting
Leukemia
- Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002952 - Completed
Stage IV Melanoma; childhood skin cancer; Recurrent Melanoma
- Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00031733 - Completed
intraocular melanoma; Melanoma
- Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00064168 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy and Interleukin-2 After Combination Chemotherapy in Treating Patients With Relapsed or De Novo Stage II, Stage III, or Stage IV Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00101101 - Recruiting
recurrent mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
- Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00054535 - Completed
Melanoma (Skin)
- Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IIIC or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00101166 - Recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00031564 - Active, not recruiting
Stage IV Renal Cell Cancer
- Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
ClinicalTrials.gov Identifier: NCT00101309 - Active, not recruiting
recurrent neuroblastoma; recurrent tumors of the Ewing's family
- Vaccine Therapy and Interleukin-2 With or Without White Blood Cell Transplantation in Treating Patients With Recurrent Sarcomas
ClinicalTrials.gov Identifier: NCT00019279 - Completed
Recurrent Childhood Rhabdomyosarcoma; Extraosseous Ewing's Sarcoma/Primitive Neuroectodermal Tumor; Recurrent Ewing's Sarcoma/Primitive Neuroectodermal Tumor; Adult Rhabdomyosarcoma; Recurrent Childhood Soft Tissue Sarcoma; Alveolar Childhood Rhabdomyosarcoma; Recurrent Tumors of the Ewing's Family; Recurrent Adult Soft Tissue Sarcoma
- Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00032045 - Completed
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00470574 - Recruiting
Breast Cancer
- Vaccine Therapy and Radiation Therapy in Treating Patients With Carcinoembryonic Antigen-Positive Solid Tumors That Have Metastasized to the Liver
ClinicalTrials.gov Identifier: NCT00085241 - Active, not recruiting
Breast Cancer; Colorectal Cancer; Lung Cancer; Metastatic Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Vaccine Therapy and Radiation to Liver Metastasis in Patients with CEA-Positive Solid Tumors
ClinicalTrials.gov Identifier: NCT00081848 - Recruiting
Liver Neoplasms
- Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery
ClinicalTrials.gov Identifier: NCT00470379 - Recruiting
Melanoma (Skin)
- Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00071955 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
- Vaccine Therapy and Sargramostim in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00091000 - Recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; unspecified adult solid tumor, protocol specific
- Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00005630 - Completed
stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage II non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer; ...
- Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
ClinicalTrials.gov Identifier: NCT00069940 - Active, not recruiting
Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer
- Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00027911 - Active, not recruiting
adult soft tissue sarcoma; adult synovial sarcoma
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00088933 - Active, not recruiting
Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy Before and After Dose-Intensive Induction Chemotherapy Plus Immune-Depleting Chemotherapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053170 - Recruiting
Breast Cancer
- Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
ClinicalTrials.gov Identifier: NCT00084383 - Completed
stage I pancreatic cancer; stage II pancreatic cancer; duct cell adenocarcinoma of the pancreas
- Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00006478 - Recruiting
recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
- Vaccine Therapy for Follicular Lymphoma
ClinicalTrials.gov Identifier: NCT00008996 - Completed
Follicular Lymphoma
- Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
ClinicalTrials.gov Identifier: NCT00186316 - Active, not recruiting
Multiple Myeloma
- Vaccine Therapy for Patients with Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00052130 - Active, not recruiting
Malignant Melanoma
- Vaccine Therapy for Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00052156 - Active, not recruiting
Malignant Melanoma
- Vaccine Therapy in Preventing Cervical Cancer in Patients with Cervical Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00121173 - Recruiting
Cervical Cancer; high-grade squamous intraepithelial lesion
- Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00054041 - Completed
Cervical Cancer; Precancerous/Nonmalignant Condition
- Vaccine Therapy in Preventing Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
ClinicalTrials.gov Identifier: NCT00128661 - Active, not recruiting
Cervical Cancer; high-grade squamous intraepithelial lesion
- Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00022035 - Completed
childhood acute lymphoblastic leukemia in remission; Infection
- Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
Breast Cancer; Male Breast Cancer
- Vaccine Therapy in Treating Patients Who Are Being Considered For a Solid Organ Transplant and Are at Risk For Post-Transplant Lymphoproliferative Disorder
ClinicalTrials.gov Identifier: NCT00278200 - Recruiting
Lymphoma
- Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
ClinicalTrials.gov Identifier: NCT00107211 - Recruiting
intraductal breast carcinoma; breast cancer in situ
- Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00098917 - Recruiting
stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
- Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00478062 - Recruiting
Lymphoma
- Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00010309 - Active, not recruiting
Stage IV Melanoma; stage II melanoma; stage III melanoma
- Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
ClinicalTrials.gov Identifier: NCT00509691 - Recruiting
Cancer
- Vaccine Therapy in Treating Patients Who Have Undergone Autologous Stem Cell Transplant for High-Risk Lymphoma or Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00569309 - Not yet recruiting
Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Small Intestine Cancer
- Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00020670 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; ...
- Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00100971 - Suspended
adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
- Vaccine Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00004881 - Completed
unspecified adult solid tumor, protocol specific
- Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00004880 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00027534 - Completed
Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
- Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
ClinicalTrials.gov Identifier: NCT00019110 - Completed
Anal Cancer; Cervical Cancer; Esophageal Cancer; Head and Neck Cancer; Penile Cancer; Vulvar Cancer
- Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005039 - Completed
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Advanced Refractory or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00075790 - Recruiting
Lung Cancer
- Vaccine Therapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004156 - Active, not recruiting
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Vaccine Therapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00524277 - Recruiting
Breast Cancer
- Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
ClinicalTrials.gov Identifier: NCT00012246 - Completed
Gastrointestinal Cancer
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00004052 - Active, not recruiting
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00030303 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00428077 - Recruiting
Leukemia
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
ClinicalTrials.gov Identifier: NCT00019006 - Completed
Recurrent Colon Cancer; Extensive Stage Small Cell Lung Cancer; Stage III Pancreatic Cancer; Stage III Rectal Cancer; Limited Stage Small Cell Lung Cancer; Recurrent Pancreatic Cancer; Recurrent Rectal Cancer; Stage III Non-Small Cell Lung Cancer; Stage I Pancreatic Cancer; Stage II Non-Small Cell Lung Cancer; Stage IVB Pancreatic Cancer; Stage II Pancreatic Cancer; Stage III Colon Cancer; Stage IVA Pancreatic Cancer
- Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
ClinicalTrials.gov Identifier: NCT00033748 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
- Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00023634 - Active, not recruiting
adult brain tumor; Gastric Cancer; ovarian epithelial cancer; Prostate Cancer
- Vaccine Therapy in Treating Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00404339 - Recruiting
Head and Neck Cancer
- Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019890 - Completed
Stage IV Melanoma; Stage III Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00014131 - Recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00096629 - Active, not recruiting
recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Vaccine Therapy in Treating Patients With Liver Cancer
ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
- Vaccine Therapy in Treating Patients With Liver Cancer
ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
- Vaccine Therapy in Treating Patients With Liver Metastases From Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00103142 - Recruiting
Colon Cancer; liver metastases; Rectal Cancer
- Vaccine Therapy in Treating Patients With Malignant Glioma
ClinicalTrials.gov Identifier: NCT00068510 - Recruiting
adult glioblastoma; adult anaplastic astrocytoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma; ...
- Vaccine Therapy in Treating Patients With Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00128583 - Active, not recruiting
stage III melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00003895 - Completed
stage I melanoma; stage II melanoma; stage III melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00003556 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00052988 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00020358 - Completed
Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Melanoma of the Eye
ClinicalTrials.gov Identifier: NCT00036816 - Active, not recruiting
ciliary body and choroid melanoma, medium/large size
- Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003761 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00071942 - Completed
stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00020267 - Completed
Lung Cancer; Adult Soft Tissue Sarcoma; Colorectal Cancer; Bone Cancer; Ovarian Sarcoma; Melanoma; Colon Cancer; Rectal Cancer; Breast Cancer; Eye Cancer; Uterine Sarcoma
- Vaccine Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00021164 - Completed
Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific
- Vaccine Therapy in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00019526 - Active, not recruiting
Kidney Cancer
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002817 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003224 - Active, not recruiting
Stage IV Melanoma; stage II melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003792 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00022568 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00087373 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019734 - Completed
Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019994 - Completed
Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00334776 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
ClinicalTrials.gov Identifier: NCT00020475 - Completed
Extraocular Extension Melanoma; Recurrent Intraocular Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
ClinicalTrials.gov Identifier: NCT00003229 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
ClinicalTrials.gov Identifier: NCT00017537 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV non-small cell lung cancer; unspecified adult solid tumor, protocol specific; ...
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004211 - Completed
stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004029 - Completed
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00010127 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005947 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005992 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00030693 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Vaccine Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00019097 - Completed
Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003959 - Active, not recruiting
Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ...
- Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00361296 - Recruiting
Myelodysplastic Syndromes
- Vaccine Therapy in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence After Standard Therapy
ClinicalTrials.gov Identifier: NCT00112541 - Active, not recruiting
stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
- Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00309829 - Recruiting
Kidney Cancer
- Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00023985 - Active, not recruiting
stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
- Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00066729 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; ...
- Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00006041 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00389610 - Recruiting
Anorexia; Fatigue; Pain; Pancreatic Cancer; Psychosocial Effects/Treatment
- Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00466726 - Recruiting
Leukemia
- Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
stage II melanoma
- Vaccine Therapy in Treating Patients With Progressive or Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00098449 - Recruiting
Prostate Cancer
- Vaccine Therapy in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00066261 - Suspended
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Vaccine Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00408590 - Recruiting
Ovarian Cancer; Peritoneal Cavity Cancer
- Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00561756 - Recruiting
Lymphoma
- Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00003977 - Completed
stage III cervical cancer; recurrent cervical cancer; stage IB cervical cancer; stage IIB cervical cancer; stage IVB cervical cancer; ...
- Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019383 - Completed
Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00109811 - Completed
adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00005628 - Completed
stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma
- Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00471471 - Not yet recruiting
Intraocular Melanoma; Malignant Conjunctival Neoplasm; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00020397 - Completed
Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
ClinicalTrials.gov Identifier: NCT00057915 - Completed
unspecified adult solid tumor, protocol specific
- Vaccine Therapy in Treating Patients With Relapsed Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002821 - Recruiting
recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
- Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer
ClinicalTrials.gov Identifier: NCT00514072 - Recruiting
Prostate Cancer
- Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003025 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas
- Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00103116 - Active, not recruiting
stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
- Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
ClinicalTrials.gov Identifier: NCT00003974 - Active, not recruiting
stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; localized malignant mesothelioma; stage I non-small cell lung cancer
- Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00003274 - Active, not recruiting
stage II melanoma
- Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That has Been Removed During Surgery
ClinicalTrials.gov Identifier: NCT00016133 - Completed
stage II colon cancer; stage III colon cancer; adenocarcinoma of the colon
- Vaccine Therapy in Treating Patients With Stage II or Stage III Melanoma That Has Been Surgically Removed
ClinicalTrials.gov Identifier: NCT00045383 - Recruiting
stage II melanoma; stage III melanoma
- Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00112957 - Recruiting
Fallopian Tube Cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
ClinicalTrials.gov Identifier: NCT00093548 - Completed
adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
- Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00104845 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00398073 - Recruiting
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00091286 - Recruiting
Colon Cancer; Rectal Cancer
- Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00019929 - Completed
Lung Cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00304096 - Recruiting
Breast Cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005816 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00091403 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005633 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005841 - Completed
ciliary body and choroid melanoma, medium/large size; Stage IV Melanoma; extraocular extension melanoma; recurrent intraocular melanoma; ...
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00053391 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00056134 - Recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085397 - Recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085488 - Completed
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00390338 - Recruiting
Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
ClinicalTrials.gov Identifier: NCT00086866 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00003386 - Completed
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy
ClinicalTrials.gov Identifier: NCT00503568 - Recruiting
Lung Cancer
- Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission
ClinicalTrials.gov Identifier: NCT00227474 - Not yet recruiting
Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
- Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
ClinicalTrials.gov Identifier: NCT00074295 - Active, not recruiting
Bronchoalveolar Cell Lung Cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
- Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
ClinicalTrials.gov Identifier: NCT00534209 - Recruiting
Lung Cancer
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00104780 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma
ClinicalTrials.gov Identifier: NCT00074230 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00021424 - Completed
Head and Neck Cancer; Metastatic Cancer
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00023647 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003665 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00033228 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00042783 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00126685 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00039325 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma
ClinicalTrials.gov Identifier: NCT00012064 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00005617 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
transitional cell carcinoma of the bladder; stage I bladder cancer
- Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00004148 - Completed
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00107159 - Active, not recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003184 - Completed
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003638 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma
ClinicalTrials.gov Identifier: NCT00107185 - Recruiting
high-grade childhood cerebral astrocytoma; low-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma; ...
- Vaccine Therapy in Treating Young Patients With Newly Diagnosed Metastatic or Recurrent Ewing Sarcoma Family of Tumors, Rhabdomyosarcoma, or Neuroblastoma
ClinicalTrials.gov Identifier: NCT00526240 - Recruiting
Neuroblastoma; Sarcoma
- Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00019331 - Completed
Colorectal Cancer; Endometrial Cancer; Head and Neck Cancer; Liver Cancer; Lung Cancer; Melanoma (Skin); Pancreatic Cancer; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
recurrent prostate cancer
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
recurrent prostate cancer
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Vaccine Therapy Plus Donor Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00020306 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00004918 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00003362 - Completed
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
ClinicalTrials.gov Identifier: NCT00020462 - Completed
Lymphoma
- Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00019916 - Completed
Breast Cancer; Ovarian Cancer
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
stage III melanoma
- Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00006387 - Completed
recurrent colon cancer; adenocarcinoma of the rectum; recurrent pancreatic cancer; stage IVA pancreatic cancer; Stage IV rectal cancer; ...
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004929 - Active, not recruiting
recurrent prostate cancer
- Vaccine Therapy Plus QS21 in Treating Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005632 - Active, not recruiting
recurrent prostate cancer
- Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00036933 - Active, not recruiting
stage III prostate cancer; recurrent prostate cancer
- Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
ClinicalTrials.gov Identifier: NCT00004249 - Active, not recruiting
limited stage small cell lung cancer
- Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease
ClinicalTrials.gov Identifier: NCT00003357 - Active, not recruiting
stage I breast cancer; stage III breast cancer; stage II breast cancer
- Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
ClinicalTrials.gov Identifier: NCT00006470 - Completed
stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
- Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00052351 - Completed
Breast Cancer
- Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00020254 - Active, not recruiting
Prostate Cancer
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004197 - Active, not recruiting
Lymphoma
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004198 - Active, not recruiting
stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
- Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
ClinicalTrials.gov Identifier: NCT00005023 - Completed
stage IV non-small cell lung cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage III ovarian epithelial cancer; ...
- Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00071981 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00082641 - Recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00003897 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003568 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With Immune Adjuvant in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085137 - Active, not recruiting
Recurrent Melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00093834 - Recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy with Or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00118274 - Recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00450814 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00045227 - Completed
Prostate Cancer
- Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00469820 - Recruiting
Leukemia; Multiple Myeloma and Plasma Cell Neoplasm
- Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00093522 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003339 - Active, not recruiting
Stage IV Melanoma; recurrent intraocular melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00303836 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00019591 - Completed
stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019214 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019448 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019487 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019669 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019721 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment
ClinicalTrials.gov Identifier: NCT00022438 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00019175 - Completed
Melanoma (Skin)
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00004025 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Montanide ISA-51 and/or Imiquimod in Treating Patients With Melanoma That Has Been Removed By Surgery
ClinicalTrials.gov Identifier: NCT00304057 - Recruiting
Melanoma (Skin)
- Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
ClinicalTrials.gov Identifier: NCT00089063 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00028496 - Completed
Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00037037 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089193 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy with Tumor Specific Mutated P53 or Ras Peptides Alone or in Combination with Cellular Immunotherapy with Peptide Activated Lymphocytes (PAL Cells) Along with Subcutaneous IL-2
ClinicalTrials.gov Identifier: NCT00001434 - Completed
Breast Cancer; Colonic Neoplasm; Female Genital Neoplasm; Lung Cancer; Pancreatic Cancer
- Vaccine Therapy with Tumor Specific Mutated RAS Peptides and IL-2 or GM-CSF for Adult Patients with Solid Tumors
ClinicalTrials.gov Identifier: NCT00001581 - Completed
Colonic Neoplasm; Lung Neoplasm; Neoplasm; Pancreatic Neoplasm; Thyroid Neoplasm
- Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00001703 - No longer recruiting
Renal Cell Carcinoma
- Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00002773 - Completed
stage III pancreatic cancer; recurrent pancreatic cancer; stage IVB pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas; ...
- Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
ClinicalTrials.gov Identifier: NCT00091039 - Completed
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00305760 - Recruiting
Pancreatic Cancer
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
unspecified adult solid tumor, protocol specific
- Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV
ClinicalTrials.gov Identifier: NCT00381875 - Recruiting
Aids-Related Malignancies
- Vaccine Therapy, Interferon alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00095862 - Recruiting
recurrent breast cancer; stage IV breast cancer
- Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
ClinicalTrials.gov Identifier: NCT00003125 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage III pancreatic cancer; stage IV breast cancer; stage IIIA non-small cell lung cancer; ...
- Vaccine Therapy, MDX-010, and GM-CSF in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00124670 - Recruiting
recurrent prostate cancer; stage IV prostate cancer
- Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00373217 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00266110 - Recruiting
Breast Cancer
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00088985 - Recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Vaccine Treatment for Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00090480 - Terminated
Breast Cancer
- Vaccine Treatment for Advanced Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00300612 - Completed
Malignant Melanoma
- Vaccine Treatment for Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00069043 - Completed
Melanoma
- Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00073398 - Recruiting
Carcinoma, Non-Small-Cell Lung
- Vaccine Treatment for Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00105053 - Completed
Prostate Cancer
- Vaccine Treatment for Surgically Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00255827 - Completed
Pancreatic Cancer
- Vaccine Treatment in Combination with IL-2 and Treated Lymphocytes for Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00080353 - Recruiting
Melanoma
- Vaccine Treatment of Kidney Cancer
ClinicalTrials.gov Identifier: NCT00089778 - Recruiting
- Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00258687 - Recruiting
Sarcoma, Clear Cell; Sarcoma, Alveolar Soft Part; Renal Cell Carcinoma; Melanoma
- Vaccines to Treat Metastatic Carcinoma
ClinicalTrials.gov Identifier: NCT00088413 - Recruiting
Adenocarcinoma
- Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
ClinicalTrials.gov Identifier: NCT00006630 - Terminated
Healthy; Communicable Diseases
- Vaccinia virus vaccine (APSV) in vaccinia- naive subjects: PILOT
ClinicalTrials.gov Identifier: NCT00038987 - Completed
Smallpox
- Vacuum Suspension: Effects On Tissue Oxygenation, Activity and Fit
ClinicalTrials.gov Identifier: NCT00117793 - Not yet recruiting
Amputation; Traumatic Amputations; Diabetes; Leg Injuries
- Vagal Blocking for Obesity Control
ClinicalTrials.gov Identifier: NCT00555958 - Enrolling by invitation
Obesity
- Vagal Tone and Neonatal Abstinence Syndrome
ClinicalTrials.gov Identifier: NCT00496951 - Recruiting
Neonatal Abstinence Syndrome; Vagal Tone
- Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
ClinicalTrials.gov Identifier: NCT00517140 - Completed
Pregnancy; Cesarean Section; Uterine Rupture
- Vaginal Birth After Caesarean Section – Effect on Maternal Psychosocial Function
ClinicalTrials.gov Identifier: NCT00294411 - Completed
Vaginal Birth After Cesarean
- Vaginal Changes and Sexual Function in Patients With Cervical Cancer
ClinicalTrials.gov Identifier: NCT00053261 - Active, not recruiting
sexuality and reproductive issues; stage IB cervical cancer
- Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial
ClinicalTrials.gov Identifier: NCT00386477 - Recruiting
Cesarean Section; Endometritis; Surgical Wound Infection
- Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometriod Cancer
ClinicalTrials.gov Identifier: NCT00542490 - Recruiting
Surgically Staged Endometrial Cancer; Stage IIb Endometrial Cancer; Stage I-IIb Papillary Serous; Stage I-IIb Clear Cell Endometrial Cancer
- Vaginal Estrogen for the Treatment of Faecal Incontinence in Women
ClinicalTrials.gov Identifier: NCT00307775 - Completed
Fecal Incontinence
- Vaginal Heat Wash-Out in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder).
ClinicalTrials.gov Identifier: NCT00443248 - Recruiting
Sexual Dysfunction, Physiological
- Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial
ClinicalTrials.gov Identifier: NCT00247169 - Recruiting
Cervical Intraepithelial Neoplasia (CIN)
- Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
ClinicalTrials.gov Identifier: NCT00536003 - Recruiting
Preterm Delivery; Morbidity; Perinatal Mortality
- Vaginal Progesterone to Reduce the Risk of Another Preterm Birth
ClinicalTrials.gov Identifier: NCT00086177 - Active, not recruiting
Pregnancy
- Vaginal Progesterone Versus Placebo in Multiple Pregnancy
ClinicalTrials.gov Identifier: NCT00343265 - Recruiting
Preterm Birth
- Vagus Nerve Stimulation in Fibromyalgia
ClinicalTrials.gov Identifier: NCT00294281 - Recruiting
Fibromyalgia
- Valaciclovir to Prevent Transmission of Herpes Simplex Virus
ClinicalTrials.gov Identifier: NCT00001649 - Completed
Herpes Simplex
- Valacyclovir for longterm therapy of Herpes simplex encephalitis
ClinicalTrials.gov Identifier: NCT00031486 - Recruiting
Encephalitis, Herpes Simplex
- Valacyclovir in Immunocompromised Children
ClinicalTrials.gov Identifier: NCT00059592 - Completed
Shingles; Bone Marrow Transplantation
- Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00045292 - Active, not recruiting
Cancer; Infection
- Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
ClinicalTrials.gov Identifier: NCT00297011 - Active, not recruiting
Herpes Labialis
- Valdecoxib in Treating Chronic Pain in Cancer Patients
ClinicalTrials.gov Identifier: NCT00021996 - Completed
Pain; unspecified adult solid tumor, protocol specific
- VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00171132 - Completed
Hypertension
- VALEO: A Post Authorization Survey, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
ClinicalTrials.gov Identifier: NCT00440765 - Recruiting
Hematological Malignancy; Multiple Myeloma
- VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
ClinicalTrials.gov Identifier: NCT00171067 - Completed
Hypertension
- Valerian to Improve Sleep in Patients with Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00070928 - Completed
Insomnia; Parkinson's Disease
- Valeriana Officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
ClinicalTrials.gov Identifier: NCT00075842 - Active, not recruiting
Sleep Disorders; unspecified adult solid tumor, protocol specific; Fatigue
- Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
ClinicalTrials.gov Identifier: NCT00471991 - Completed
Oral Contraception
- Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
ClinicalTrials.gov Identifier: NCT00478465 - Active, not recruiting
Chronic Fatigue Syndrome
- Valganciclovir in Patients with CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
ClinicalTrials.gov Identifier: NCT00017784 - Active, not recruiting
Cytomegalovirus Retinitis; HIV Infections
- Valganciclovir in Prevention of CMV Reactivation Following Allo-SCT
ClinicalTrials.gov Identifier: NCT00330018 - Recruiting
Bone Marrow Transplantation; Cytomegalovirus
- Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00096538 - Recruiting
classic Kaposi's sarcoma; recurrent Kaposi's sarcoma
- Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00016068 - Active, not recruiting
Infection
- Valganciclovir to Reduce T Cell Activation in HIV Infection
ClinicalTrials.gov Identifier: NCT00264290 - Recruiting
HIV Infections; Cytomegalovirus Infections
- Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
ClinicalTrials.gov Identifier: NCT00361933 - Not yet recruiting
Giant Lymph Node